Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Timo Minnemann"'
Autor:
Mary Ellen Boers, Ed Hadro, Barbara B. Kahn, James C.A. Hopkins, E. Dale Abel, Bradford B. Lowell, Joanne S. Ingwall, Helen C. Kaulbach, Rong Tian, William C. Quist, Timo Minnemann, Corinna Oberste-Berghaus, Thomas Doetschman, John J. Duffy
Publikováno v:
Journal of Clinical Investigation. 104:1703-1714
Glucose enters the heart via GLUT1 and GLUT4 glucose transporters. GLUT4-deficient mice develop striking cardiac hypertrophy and die prematurely. Whether their cardiac changes are caused primarily by GLUT4 deficiency in cardiomyocytes or by metabolic
Autor:
Julia K. Bickmann, Jürgen J. Wenzel, Heidi Rossmann, Karl J. Lackner, Carolin Neukirch, Thomas J. Musholt, Christian Fottner, Peter Lohse, Matthias M. Weber, Timo Minnemann, Stefan Neuwirth, Brigitte Schneider-Rätzke
Publikováno v:
Clinical chemistry. 55(7)
Background: Reliable PCR amplification of DNA fragments is the prerequisite for most genetic assays. We investigated the impact of G-quadruplex– or i-motif–like sequences on the reliability of PCR-based genetic analyses. Methods: We found the seq
Publikováno v:
Journal of molecular endocrinology. 36(2)
In order to determine the role of the IGF-I receptor (IGF-IR) in human pheochromocytomas we have compared the expression of the IGF-IR in normal tissues and in pheochromocytomas with regard to the IGF-IR mRNA levels and ligand binding. By semiquantit
Autor:
Ulrich Zimmermann, Timo Minnemann, Peter J. Feilen, Matthias M. Weber, Stephan Schneider, Heiko Zimmermann, Frank Brunnenmeier
Publikováno v:
Diabetes. 54(3)
We describe the results of the first study to show that adult rat and human islets can be protected against xenogenic rejection in immunocompetent diabetic mice by encapsulating them in a novel alginate-based microcapsule system with no additional pe
Autor:
Ed Hadro, Odile D. Peroni, Timo Minnemann, Gerald I. Shulman, Olivier Boss, E. Dale Abel, Barbara B. Kahn, Young-Bum Kim, Jason K. Kim
Publikováno v:
Nature. 409(6821)
The earliest defect in developing type 2 diabetes is insulin resistance, characterized by decreased glucose transport and metabolism in muscle and adipocytes. The glucose transporter GLUT4 mediates insulin-stimulated glucose uptake in adipocytes and